前往化源商城

P-gp inhibitor 4

更新时间:2024-01-13 19:35:36

P-gp inhibitor 4结构式
P-gp inhibitor 4结构式
品牌特惠专场
常用名 P-gp inhibitor 4 英文名 P-gp inhibitor 4
CAS号 2652001-05-1 分子量 714.85
密度 N/A 沸点 N/A
分子式 C38H38N2O8S2 熔点 N/A
MSDS N/A 闪点 N/A

 P-gp inhibitor 4用途


P-gp抑制剂4(化合物8b)是一种选择性P-糖蛋白调节剂,EC50为94 nM。P-gp抑制剂4增加药物通过胃肠道屏障的转运,并恢复多药耐药癌细胞中阿霉素的毒性[1]。

 P-gp inhibitor 4名称

英文名 P-gp inhibitor 4

 P-gp inhibitor 4生物活性

描述 P-gp抑制剂4(化合物8b)是一种选择性P-糖蛋白调节剂,EC50为94 nM。P-gp抑制剂4增加药物通过胃肠道屏障的转运,并恢复多药耐药癌细胞中阿霉素的毒性[1]。
相关类别
靶点

EC50: 94 nM (P-glycoprotein)[1]

体外研究 P-gp抑制剂4(化合物8b)(0-1μM,48小时)显著增加联合给药的抗肿瘤药物的细胞毒性作用[1]。P-gp抑制剂4不会改变Caco-2细胞屏障模型的生理特性【1】。P-gp抑制剂4选择性地降低P-gp的活性,并增加多种P-gp底物通过胃肠屏障的转运[1]。细胞增殖试验【1】细胞系:MDCK-MDR1浓度:100 nM、500 nM和1μM培养时间:48 h结果:无细胞毒性。显著增强抗肿瘤药物的细胞毒性作用。细胞活力测定【1】细胞系:Caco-2细胞浓度:0.1 nM-100µM培养时间:72 h结果:显示出剂量依赖性细胞毒性,在≥ 10μM浓度。在100 nM时没有降低细胞活力。
参考文献

[1]. Contino M, et al. One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells. Eur J Med Chem. 2020 Dec 15;208:112843.

 P-gp inhibitor 4物理化学性质

分子式 C38H38N2O8S2
分子量 714.85
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:

暂无推荐供应商。我要出现这里

相关化合物: 更多...
P-gp inhibitor 5
2451298-06-7
P-gp inhibitor 2
2408406-89-1
P-gp inhibitor 1
2050747-49-2
Valspodar
121584-18-7
p-[4,5-dihydro-4-[[2-methoxy-5-methyl-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid
60958-41-0
p-[[4-[(2-hydroxy-1-naphthyl)azo]phenyl]azo]benzenesulphonic acid, compound with 2-(dimethylamino)ethanol (1:1)
84878-18-2
p-[4,5-dihydro-4-[3-[5-hydroxy-3-methyl-1-(4-sulphophenyl)-1H-pyrazol-4-yl]but-2-enylidene]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid
27981-70-0
p-[[(4-chlorobutyl)sulphonyl]amino]benzenesulphonamide
74220-53-4
p-[(4,6-Diamino-1,3,5-triazin-2-yl)amino]phenylstibonic acid
587-31-5
N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)pivalamide
921565-46-0
N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)-4-(trifluoromethyl)benzamide
921865-05-6
N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)cyclopentanecarboxamide
921792-75-8
N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)-2-(thiophen-2-yl)acetamide
921565-54-0
2-fluoro-N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)benzamide
921865-08-9
N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)cyclopropanecarboxamide
921792-79-2
4-fluoro-N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)benzamide
921522-59-0
2-(4-fluorophenyl)-N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)acetamide
921565-61-9
N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)-2-(trifluoromethyl)benzamide
921865-11-4
2-chloro-6-fluoro-N-(5-isobutyl-3,3-dimethyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-7-yl)benzamide
921792-83-8